Oka, Shomi
Furukawa, Hiroshi
Shimada, Kota
Hashimoto, Atsushi
Komiya, Akiko
Fukui, Naoshi
Tsuchiya, Naoyuki
Tohma, Shigeto
Funding for this research was provided by:
Japan Society for the Promotion of Science (24791018, 15K09543)
Ministry of Health, Labour and Welfare
National Hospital Organization
Daiwa Securities Health Foundation
Japan Research Foundation for Clinical Pharmacology
The Nakatomi Foundation
Takeda Science Foundation
Mitsui Sumitomo Insurance Welfare Foundation
Abbott Japan Co., Ltd.
Astellas Pharma Inc.
Chugai Pharmaceutical Co., Ltd.
Eisai Co., Ltd.
Mitsuibishi Tanabe Pharma Corporation
Merck Sharp and Dohme Inc.
Pfizer Japan Inc.
Takeda Pharmaceutical Company Limited
Teijin Pharma Limited
Bristol-Myers Squibb Co.
Japan Agency for Medical Research and Development
Article History
Received: 7 June 2016
Accepted: 4 January 2017
First Online: 19 January 2017